Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 2026 → Dec 31, 2027
See other at-risk trials from Douglas Scharre

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2026 to Dec 31, 2027
    • Primary endpoints: details revised at 2 of 35 entries
    • Eligibility criteria expanded, about 12 words
  2. Primary and study completion dates: Dec 2024 to Dec 2026v11
  3. Primary and study completion dates: Dec 2023 to Dec 2024v10
  4. Primary and study completion dates: Dec 2022 to Dec 2023v9
  5. Primary and study completion dates: Dec 2020 to Dec 2022v8
Show 6 earlier versionsHide 6 earlier versions
  1. Re-verified, no change to tracked fieldsv7
  2. Start date changed from estimate of Aug 21, 2019 to Aug 30, 2018v6
  3. Start date: Nov 2018 to Aug 21, 2019v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Aug 2018 to Nov 2018
    • Site details revised
    v4
  5. Primary completion date: Dec 2017 to Dec 2020
    • Start date: Oct 2017 to Aug 2018
    • Study completion date: Dec 2018 to Dec 2020
    v3
  6. Start date: Mar 2017 to Oct 2017v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Douglas Scharre
2 trials monitored
See 1 trial at risk
Dementia
1,982 trials monitored
See 105 trials at risk
Parkinson's Disease
1,462 trials monitored
See 71 trials at risk
Alzheimer's Disease
1,255 trials monitored
See 68 trials at risk
The study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease.
Trial Details
NCT Number NCT03019757
Lead Sponsor Douglas Scharre
Collaborators: Avid Radiopharmaceuticals, Mangurian Foundation
Conditions
(from sponsor)		 Alzheimer's Disease, Lewy Body Dementia, Parkinson's Disease
Related terms Alzheimer Disease, Lewy Body Disease, Parkinson Disease
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov